Comparing tumour site and overall survival in colon v. rectal cancer in a longitudinal cohort study in Johannesburg, South Africa
DOI:
https://doi.org/10.7196/SAMJ.2026.v116i6.4087Keywords:
Tumour , colon, rectum, cancer, South Africa, Johannesburg, Colorectal cancer; Sidedness; sub-Saharan Africa, Colon Cancer, Rectal cancer, Colorectal cancer, Tumour location, Survival analysis, Overall survival, Prognosis, Epidemiology, Cohort study, Johannesburg, South Africa, Cancer outcomes, Site-specific survivalAbstract
Background. Colorectal cancer (CRC) incidence is increasing globally, with disproportionately high mortality in low- and middle-income countries. Although colon and rectal cancers are often grouped together, anatomical, molecular and clinical differences suggest they may be distinct entities, warranting unique work-up, management and diagnosis. Data from sub-Saharan Africa comparing clinical presentation and mortality outcomes among those with colon and rectal cancer remain limited. This study aimed to address this knowledge gap.
Objectives. To compare the clinicopathological features, associated risk factors and overall survival (OS) of patients with colon and rectal cancers in the cohort from the Colorectal Cancer in South Africa Study in Johannesburg, South Africa (SA).
Methods. The cohort eligible for inclusion in this study comprised 325 patients, recruited from 2016 to 2019, with follow-up to January 2023. Sociodemographic, clinical, treatment and OS data were analysed. Comparison by tumour location was made using t-tests and ANOVA. Cox proportional hazards regression models assessed associations with OS. Kaplan-Meier analysis was used for survival estimation.
Results. Rectal cancers accounted for 52.3% of cases, right-sided colon cancers 26.2% and left-sided colon cancers 21.5%. When comparing those who presented with colon v. rectal cancers, no significant differences were observed in self-reported ethnicity, socioeconomic status (SES), family history of cancer, tobacco use, body mass index, or presence of comorbidities. Alcohol use was more common among those with colon cancer (p=0.035), and treatment differed significantly by tumour site (p<0.0001). Male sex (hazard ratio (HR) 1.81, 95% confidence interval (CI) 1.25 - 2.61, p=0.0017), low SES (HR 3.24, CI 1.86 - 5.65, p<0.0001) and distant disease at presentation (HR 3.85, CI 2.26 - 6.57, p<0.0001) were most strongly associated with poorer OS. The tumour site had no impact on OS.
Conclusion. In this SA cohort of patients with CRC, tumour site did not affect overall survival. However, male sex, advanced stage at diagnosis and low socioeconomic status were associated with poorer OS.
References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clinicians 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
2. Moen L, Liu B, Bukirwa P, et al. Trends in the incidence of colorectal cancer in sub-Saharan Africa: A population-based registry study. Intl J Cancer 2024;155(4):675-682. https://doi.org/10.1002/ijc.34942
3. Motsuku L, Chen WC, Muchengeti MM, et al. Colorectal cancer incidence and mortality trends by sex and population group in South Africa: 2002 - 2014. BMC Cancer 2021;21(1):129. https://doi. org/10.1186/s12885-021-07853-1
4. Paschke S, Jafarov S, Staib L, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. IJMS 2018;19(9):2577. https://doi.org/10.3390/ijms19092577
5. Li F, Lai M. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009;10(3):219-229. https://
doi.org/10.1631/jzus.B0820273
6. Lacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101(5):403-408. https://doi.
org/10.1002/ijc.10635
7. Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53(1):57-64. https://doi.org/10.1007/DCR.0b013e3181c703a4
8. Hemminki K, Chen B. Familial association of colorectal adenocarcinoma with cancers at other sites. Euro J Cancer 2004;40(16):2480-2487. https://doi.org/10.1016/j.ejca.2004.07.016
9. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Intl J Cancer 2004;108(3):433-442. https://doi.org/10.1002/ijc.11540
10. Samad AKA, Taylor RS, Marshall T, Chapman MS. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 2005;7(3):204-213. https://doi. org/10.1111/j.1463-1318.2005.00747.x
11. Harriss DJ, Atkinson G, Batterham A, et al. Lifestyle factors and colorectal cancer risk (2): A systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Dis 2009;11(7):689-701. https://doi.org/10.1111/j.1463-1318.2009.01767.x
12. Doubeni CA, Major JM, Laiyemo AO, et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst 2012;104(18):1353-1362. https://doi.org/10.1093/jnci/djs346
13. Nilbert M, Planck M, Fernebro E, Borg Å, Johnson A. Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Euro J Cancer 1999;35(6):942-945. https://doi.org/10.1016/ S0959-8049(99)00045-3
14. Frattini M, Balestra D, Suardi S, et al. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004;10(12):4015-4021. https://doi.org/10.1158/1078-0432.CCR- 04-0031
15. Rosenberg R, Maak M, Schuster T, Becker K, Friess H, Gertler R. Does a rectal cancer of the upper third behave more like a colon or a rectal cancer? Dis Colon Rectum 2010;53(5):761-770. https://doi. org/10.1007/DCR.0b013e3181cdb25a
16. Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Oncology 2007;73(1-2):52-57.
https://doi.org/10.1159/000120628
17. Duraes LC, Steele SR, Valente MA, Lavryk OA, Connelly TM, Kessler H. Right colon, left colon, and rectal cancer have different oncologic and quality of life outcomes. Int J Colorectal Dis 2022;37(4):939- 948. https://doi.org/10.1007/s00384-022-04121-x
18. Lee YC, Lee YL, Chuang JP, Lee JC. Differences in survival between colon and rectal cancer from SEER data. PLoS ONE 2013;8(11):e78709. https://doi.org/10.1371/journal.pone.0078709
19. Van der Sijp MPL, Bastiaannet E, Mesker WE, et al. Differences between colon and rectal cancer in complications, short-term survival and recurrences. Int J Colorectal Dis 2016;31(10):1683-1691. https://doi.org/10.1007/s00384-016-2633-3
20. Buchwald P, Hall C, Davidson C, et al. Improved survival for rectal cancer compared to colon cancer: The four-cohort study. ANZ J Surg 2018;88(3):E114-E117. https://doi.org/10.1111/ans.13730
21. Alatise OI, Knapp GC, Sharma A, et al. Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights. Nat Commun 2021;12(1):6821. https://doi. org/10.1038/s41467-021-27106-w
22. Amer A, Boutall AB, Coetzee ED, et al. Epidemiology and anatomic distribution of colorectal cancer in South Africa. S Afr J Surg 2024;62(4):30-34. https://doi.org/10.36303/SAJS.00255
23. Katsidzira L, Vorster A, Gangaidzo IT, et al. Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases. PLoS ONE 2019;14(10):e0224023. https://doi. org/10.1371/journal.pone.0224023
24. McCabe M, Perner Y, Magobo R, Magangane P, Mirza S, Penny C. Microsatellite instability assessment in black South African colorectal cancer patients reveal an increased incidence of suspected Lynch syndrome. Sci Rep 2019;9(1):15019. https://doi.org/10.1038/s41598-019-51316-4
25. Wentink MQ, Räkers M, Stupart DA, Algar U, Ramesar R, Goldberg PA. Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa. S Afr J Surg 2010;48(4):109-113. https://pubmed.ncbi.nlm.nih.gov/21542398/ (accessed 26 June 2026).
26. Bebington B, Singh E, Fabian J, et al. Design and methodology of a study on colorectal cancer in Johannesburg, South Africa. JGH Open 2018;2(4):139-143. https://doi.org/10.1002/jgh3.12061
27. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomedical Informatics 2019;95:103208. https://doi.org/10.1016/j. jbi.2019.103208
28. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomedical Informatics 2009;42(2):377-381. https://doi.org/10.1016/j. jbi.2008.08.010
29. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data – or tears: An application to educational enrollments in states of India. Demography 2001;38(1):115-132. https://doi.org/10.1353/ dem.2001.0003
30. Bouter C, Bebington B, Maphosa S, et al. It’s contrary – comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort. S Afr Med J 2020;110(5):382. https://doi.org/10.7196/SAMJ.2020.v110i5.14252
31. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more ‘personalised’ approach to cancer staging. CA Cancer J Clin 2017;67(2):93-99. https://doi.org/10.3322/caac.21388
32. Dukes CE. The classification of cancer of the rectum. J Pathol 1932;35(3):323-332. https://doi. org/10.1002/path.1700350303
33. Brierley J, Gospodarowicz MK, Wittekind C, Brierley J. TNM Classification of Malignant Tumours. 8th ed. Chichester: John Wiley & Sons, Incorporated, 2017.
34. Brand M, Gaylard P, Ramos J. Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. S Afr Med J 2018;108(2):118. https://doi.org/10.7196/ SAMJ.2018.v108i2.12338
35. Agyemang-Yeboah F, Yorke J, Obirikorang C, et al. Colorectal cancer survival rates in Ghana: A retrospective hospital-based study. PLoS ONE 2018;13(12):e0209307. https://doi.org/10.1371/ journal.pone.0209307
36. Asombang AW, Madsen R, Simuyandi M, et al. Descriptive analysis of colorectal cancer in Zambia, Southern Africa using the National Cancer Disease Hospital Database. Pan Afr Med J 2018;30:248. https://doi.org/10.11604/pamj.2018.30.248.12464
37. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Cancer J Clinicians 2025;75(1):10-45. https://doi.org/10.3322/caac.21871
38. Exarchakou A, Donaldson LJ, Girardi F, Coleman MP. Colorectal cancer incidence among young adults in England: Trends by anatomical sub-site and deprivation. PLoS ONE 2019;14(12):e0225547. https://doi.org/10.1371/journal.pone.0225547
39. Salem ME, Weinberg BA, Xiu J, et al. Comparative molecular analyses of left-sided colon, right- sided colon, and rectal cancers. Oncotarget 2017;8(49):86356-86368. https://doi.org/10.18632/ oncotarget.21169
40. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: A dose-response meta-analysis of published cohort studies. Intl J Cancer 2007;120(3):664-671. https://doi.org/10.1002/ ijc.22299
41. Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22(9):1958-1972. https://doi. org/10.1093/annonc/mdq653
42. Stewart CJR, Hillery S, Platell C, Puppa G. Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: Confusions, controversies and criticisms. Cancers 2011;3(1):164-181. https://doi.org/10.3390/cancers3010164
43. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorisation for colon cancer based on national survival outcomes data. JCO 2010;28(2):264-271. https://doi.org/10.1200/ JCO.2009.24.0952
44. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorisation for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. JCO 2010;28(2):256-263. https://doi.org/10.1200/JCO.2009.23.9194
45. García-Aranda M, Abitei C, Martín-García D, et al. Long-term prognostic value of apoptotic index in colorectal cancer: A 5-year multicentre cohort study. Pathology 2025;57(4):443-449. https://doi. org/10.1016/j.pathol.2024.11.009
46. Salem ME, Puccini A, Trufan SJ, et al. Impact of sociodemographic disparities and insurance status on survival of patients with early-onset colorectal cancer. Oncologist 2021;26(10):e1730-1741. https:// doi.org/10.1002/onco.13908
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 A Pincus, Y Moodley, L Campbell, D Kruger, V Soldati, J Fabian, P Gaylard, T K Marumo, L Prodehl, N Harran, B Bebington, P Ruff
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
